MEDLINE Journals

    Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine.

    Authors

    Al Jarousha AM, El Jadba AH, Al Afifi AS, et al. 

    Institution

    Laboratory Medicine Department, Al Azhar University, and Medical Microbiology Department, Al Dorra Pediatric Hospital, Gaza, Palestine. Amoati2007@yahoo.com

    Source

    Int J Infect Dis 2009 Sep; 13(5) :623-8.

    Abstract

    OBJECTIVES
    We performed a prospective case-control study of bloodstream infections in order to determine the infection rate of Acinetobacter baumannii and to determine the risk factors associated with infection and mortality.
    METHODS
    Between February 2004 and January 2005, 579 consecutive blood specimens were collected from the two neonatal intensive care units (NICUs) of Al-Nasser and Al-Shifa hospitals in Gaza City.
    RESULTS
    Forty (6.9%) isolates of A. baumannii were obtained from neonates aged under 28 days. Of the patients, 62.5% were male and 37.5% were female. Compared to matched, uninfected controls, statistically significant risk factors were weight<1500 g (odds ratio (OR) 3.89, p<0.001), age <7 days (OR 2.33, p=0.027), median hospitalization of =20 days (OR 3.1, p=0.003), mechanical ventilation (OR 3.5, p=0.001), use of a central venous catheter (CVC; OR 10.5, p<0.001), and prior antibiotic use (OR 4.85, p=0.003). The overall mortality was also significantly different (overall mortality 37.5% in cases vs. 12% in uninfected controls; OR 4.4, p=0.001). Compared to infected controls, statistically significant risk factors were mechanical ventilation (OR 2.68, p=0.008), use of a CVC (OR 6.68, p<0.001), and prior antibiotic use (OR 5.68, p=0.001). The multidrug-resistant type was significantly associated with death in the neonates (p=0.023). The isolates of A. baumannii were resistant to commonly used antibiotics, while susceptible to meropenem (92.5%), imipenem (90%), ciprofloxacin (75%), gentamicin (57.5%), and ceftriaxone (50%).
    CONCLUSIONS
    The infection rate with multidrug-resistant A. baumannii is considerable and alarming in NICU infants, and is associated with significant mortality.

    Mesh

    Acinetobacter Infections
    Acinetobacter baumannii
    Anti-Bacterial Agents
    Bacteremia
    Case-Control Studies
    Cross Infection
    Drug Resistance, Multiple, Bacterial
    Female
    Humans
    Infant, Newborn
    Infant, Very Low Birth Weight
    Intensive Care Units, Neonatal
    Length of Stay
    Male
    Middle East
    Prevalence
    Respiration, Artificial
    Risk Factors

    Language

    eng

    Pub Type(s)

    Journal Article

    PubMed ID

    19144555

    Content Manager
    Related Content

    Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit.

    [Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].

    Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital.

    [Acinetobacter baumannii: an important pathogen with multidrug resistance in newborns].

    Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.

    Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.

    Outbreak of Acinetobacter baumannii in a neonatal intensive care unit: antimicrobial susceptibility and genotyping analysis.

    An outbreak of Acinetobacter baumannii septicemia in a neonatal intensive care unit of a university hospital in Brazil.